CXCR4-targeted Theranostics in Hematooncology: Opportunities and Challenges. - Werner R; Haug A; Buske C; Heidegger S; Illert AL; Bassermann F; Herhaus P; Buck A; Duell J; Topp MS; Kraus S; Einsele H; et al. (Nuklearmedizin. Nuclear medicine, 2024)